Werkgroep Cardiologische centra Nederland English

ODYSSEY (Klaar)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experienced an Acute Coronary Syndrome.

Middel
alirocumab
Populatie
acuut coronair syndroom
Fase
IIIb
Jaar aanvang
2012
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. G.L. Bartels (Cardioloog)
Groningen, Martini Ziekenhuis

ODYSSEY: Nieuws